256940 Stock Chart & Stats
₩5350.00
-₩300.00(-5.31%)
―
--
Day’s Range― - ―
52-Week Range₩5,110.00 - ₩14,250.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)43.74K
Market Cap
₩107.42B
Enterprise Value₩209.08K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.03
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-436.50
Shares Outstanding20,078,148
10 Day Avg. Volume43,137
30 Day Avg. Volume43,736
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
256940 FAQ
What was Keeps Biopharma Inc.’s price range in the past 12 months?
Keeps Biopharma Inc. lowest stock price was ₩5110.00 and its highest was ₩14250.00 in the past 12 months.
What is Keeps Biopharma Inc.’s market cap?
Keeps Biopharma Inc.’s market cap is ₩107.42B.
When is Keeps Biopharma Inc.’s upcoming earnings report date?
Keeps Biopharma Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 81 days.
How were Keeps Biopharma Inc.’s earnings last quarter?
Keeps Biopharma Inc. released its earnings results on Aug 14, 2026. The company reported -₩436.502 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Keeps Biopharma Inc. overvalued?
According to Wall Street analysts Keeps Biopharma Inc.’s price is currently Undervalued.
Does Keeps Biopharma Inc. pay dividends?
Keeps Biopharma Inc. does not currently pay dividends.
What is Keeps Biopharma Inc.’s EPS estimate?
Keeps Biopharma Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Keeps Biopharma Inc. have?
Keeps Biopharma Inc. has 20,078,148 shares outstanding.
What happened to Keeps Biopharma Inc.’s price movement after its last earnings report?
Keeps Biopharma Inc. reported an EPS of -₩436.502 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.153%.
Which hedge fund is a major shareholder of Keeps Biopharma Inc.?
Currently, no hedge funds are holding shares in KR:256940
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ISU Abxis Co., Ltd.
―
Genexine, Inc.
―
Kyongbo Pharmaceutical Co., Ltd.
―
Aptabio Therapeutics, Inc.
―
ViGenCell, Inc.
―